Investors Overview

    Press Release

    View printer-friendly version

    BD to Present at Upcoming Investor Conferences

    FRANKLIN LAKES, N.J., Feb. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following upcoming virtual investor conferences:

    • The Leerink Virtual 10th Annual Global Healthcare Conference on Wednesday, February 24, 2021 at 1:00 p.m. Eastern Time (ET).
    • The Raymond James Virtual 42nd Annual Institutional Investors Conference on Tuesday, March 2, 2021, at 8:20 a.m. ET.

    Live webcasts of BD's presentations can be accessed on the BD corporate website at  A replay will be available for a minimum of seven days after each conference. 

    About BD
    BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit or connect with us on LinkedIn at and Twitter @BDandCo.


    Troy Kirkpatrick

    Kristen M. Stewart, CFA

    BD Public Relations

    BD Investor Relations




    Cision View original content:

    SOURCE BD (Becton, Dickinson and Company)

    Investor Highlights


    Meet Jonathan

    Moments after crossing the finish line of a half marathon, Jonathan went into cardiac arrest due to a congenital defect in his artery.

    Drone Delivery Capabilities

    See how BD and WeRobotics worked to advance drones for healthcare in the Peruvian Amazon

    AMR Leadership

    BD solutions to combat antimicrobial resistance